Answers are grounded in this paper and cite their sources.
Prologue: As a population cohort, the elderly are more dependent upon prescription drugs than any other group. Yet Medicare, the federally operated health insurance program for the elderly and disabled, stands alone among major carriers in omitting outpatient drugs from its covered benefits. In this paper Steve Long, a senior economist at RAND, examines the elderly's need for prescription drug insurance, the extent and depth of current coverage supplementary to Medicare, the characteristics of those who have such coverage and those who do not, and the problem of adverse selection in individual insurance for drugs. He also outlines options for providing broader drug coverage to the elderly. Long, who holds a doctorate in economics from the University of Wisconsin-Madison, worked previously at the Congressional Budget Office, where he supervised the agency's health and income security-related work. Much of his current research focuses on health care for people with low incomes. Long's major, though brief, involvement in charting federal prescription drug policy occurred in 1989, when he served as executive director of the Prescription Drug Payment Review Commission. Congress created this commission when it enacted the Medicare Catastrophic Coverage Act of 1988. The commission never became fully operational because Congress, in response to the outcries of affluent elderly people who already enjoyed drug coverage through supplementary insurance policies, repealed the law before its implementation. There is no question that many elderly persons need prescription drugs, but the overriding issue is how to finance their purchase. The top 11 percent of elderly, whose spending on prescription drugs averaged in excess of $100 per month in 1991 dollars, account for nearly half of spending. Despite these risks, 45 percent of the elderly had no insurance for prescription drugs in 1991. Abstract: This paper examines the elderly's need for prescription drug insurance, the extent and depth of current coverage supplementary to Medicare, the characteristics of those who have coverage and those who do not, and the problem of adverse selection in individual insurance for prescription drugs. It also discusses the issues that must be resolved in choosing the direction public policy should take if more of the elderly are to be covered and examines the advantages and disadvantages of four illustrative public policy options, ranging from small expansions of Medicaid benefits through “Medigap” regulation to Medicare coverage for all elderly.
No takes yet. Share an insight, caveat, or question.
Stephen H. Long (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: